Home › Funds › USA FINANCIAL FORMULAS › REGN
USA FINANCIAL FORMULAS position in REGN
REGENERON PHARMACEUTICALS · Health Care
USA FINANCIAL FORMULAS reported holding 980 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$743K, representing 0.14% of its reported portfolio and ranking #48 among its reported holdings. USA FINANCIAL FORMULAS has disclosed REGN holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How USA FINANCIAL FORMULAS's REGN position evolved
USA FINANCIAL FORMULAS first disclosed a stake in REGN in Q3 2023 at 2,695 shares (US$2.2M). Across 4 filings, USA FINANCIAL FORMULAS increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 980 shares valued at US$743K — a reduction of -477 shares quarter over quarter.. Notable position changes include a 33% trim in Q3 2026 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.69K | $2.22M | New |
| Q1 2024 | 852 | $820.04K | New |
| Q1 2026 | 1.46K | $1.13M | New |
| Q3 2026 | 980 | $743.11K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on USA FINANCIAL FORMULAS
FAQ
How long has USA FINANCIAL FORMULAS held REGN?
USA FINANCIAL FORMULAS has disclosed REGN holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
What is USA FINANCIAL FORMULAS's current position in REGN?
As of Q3 2026, USA FINANCIAL FORMULAS holds 980 shares of REGN (REGENERON PHARMACEUTICALS), valued at $743.11K, representing 0.14% of its reported portfolio and ranking #48.
Has USA FINANCIAL FORMULAS been buying or selling REGN?
In the latest 13F filing (Q3 2026), USA FINANCIAL FORMULAS reduced its position in REGN.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.